Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

DexCom Inc. closed 51.77% below its 52-week high of $142.00, which the company achieved on March 26th.

PowerVR AX3125 is a cost-sensitive solution for low-power applications – i.e. where power draw is a key issue. It can run at up to 0.6 TOPS in IoT devices, entry-level smart cameras, embedded ... The ...

DexCom Inc. closed 50.22% short of its 52-week high of $142.00, which the company achieved on March 26th.

DexCom has done a decent job managing its cost base over the last five years. The company has produced an average operating margin of 14.4%, higher than the broader healthcare sector. Looking at ...

DexCom's growth is slowing with 2024 marking the slowest growth year in a decade and 2025 expected to follow suit with ~14% ...

underscoring operational and cost challenges faced by the company. The quarter featured significant strategic moves, including the submission of the Dexcom G7 15-day CGM system to the FDA.

The decline was primarily due to operational and cost challenges faced by the company, which led to a fall in both gross and operating margins. Despite these challenges, DexCom's management ...